Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Apr 14 2022 | New Episode of the Heart Failure Beat Discusses Challenges in Recruiting Trainees in the Field of Advanced Heart Failure HFSA News Podcasts Provider Education Read More Apr 11 2022 | HFSA Awards: Nominations Now Open through May 9, 2022 HFSA News Awards Read More Apr 1 2022 | ACC, AHA, HFSA Issue Heart Failure Guideline HFSA News Heart Failure Guidelines In The News Journal of Cardiac Failure Press Release Research Read More Mar 30 2022 | Bayer to Highlight New Cardiovascular and Renal Data at ACC.22, Including Late-Breaking Presentations for KERENDIA® (finerenone) as Well as Oral Factor XIa Inhibitor (asundexian) Program Industry News In The News Industry Read More Mar 28 2022 | Volunteer for Committee and Leadership Positions for the 2022-2024 Term HFSA News HFSA Committees Read More Pagination First page « First Previous page ‹ Previous … Page 68 Page 69 Page 70 Page 71 Current page 72 Page 73 Page 74 Page 75 Page 76 … Next page Next › Last page Last »
Apr 14 2022 | New Episode of the Heart Failure Beat Discusses Challenges in Recruiting Trainees in the Field of Advanced Heart Failure HFSA News Podcasts Provider Education Read More
Apr 1 2022 | ACC, AHA, HFSA Issue Heart Failure Guideline HFSA News Heart Failure Guidelines In The News Journal of Cardiac Failure Press Release Research Read More
Mar 30 2022 | Bayer to Highlight New Cardiovascular and Renal Data at ACC.22, Including Late-Breaking Presentations for KERENDIA® (finerenone) as Well as Oral Factor XIa Inhibitor (asundexian) Program Industry News In The News Industry Read More
Mar 28 2022 | Volunteer for Committee and Leadership Positions for the 2022-2024 Term HFSA News HFSA Committees Read More
